Form EFFECT Tvardi Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 12, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Convenience Stores Nationwide “Serving Up Thanks” in Honor of First Responders for 24/7 Day
- AmpliTech Group Approved for Membership in the AI-RAN Alliance, the Global Consortium Founded by Leading Technology Companies to Bring Artificial Intelligence to Wireless Networks
- ConocoPhillips reaches agreement supporting redevelopment of producing oil fields in Iraq
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
